Guild and Niche Determination Enable Targeted Alteration of the Microbiome

bioRxiv [Preprint]. 2023 May 11:2023.05.11.540389. doi: 10.1101/2023.05.11.540389.

Abstract

Microbiome science has greatly contributed to our understanding of microbial life and its essential roles for the environment and human health1-5. However, the nature of microbial interactions and how microbial communities respond to perturbations remains poorly understood, resulting in an often descriptive and correlation-based approach to microbiome research6-8. Achieving causal and predictive microbiome science would require direct functional measurements in complex communities to better understand the metabolic role of each member and its interactions with others. In this study we present a new approach that integrates transcription and translation measurements to predict competition and substrate preferences within microbial communities, consequently enabling the selective manipulation of the microbiome. By performing metatranscriptomic (metaRNA-Seq) and metatranslatomic (metaRibo-Seq) analysis in complex samples, we classified microbes into functional groups (i.e. guilds) and demonstrated that members of the same guild are competitors. Furthermore, we predicted preferred substrates based on importer proteins, which specifically benefited selected microbes in the community (i.e. their niche) and simultaneously impaired their competitors. We demonstrated the scalability of microbial guild and niche determination to natural samples and its ability to successfully manipulate microorganisms in complex microbiomes. Thus, the approach enhances the design of pre- and probiotic interventions to selectively alter members within microbial communities, advances our understanding of microbial interactions, and paves the way for establishing causality in microbiome science.

Publication types

  • Preprint

Grants and funding

This material is based upon work supported by the U.S. Department of Energy, Office of Science, Office of Biological & Environmental Research under Awards DE-SC0021234 and DE-SC0022137. Furthermore, the development of the technologies described in this article were in part funded through Trial Ecosystem Advancement for Microbiome Science Program at Lawrence Berkeley National Laboratory funded by the U.S. Department of Energy, Office of Science, Office of Biological & Environmental Research Awards DE-AC02–05CH11231. The work was also supported by the UC San Diego Center for Microbiome Innovation (CMI) through a Grand Challenge Award. This publication includes data generated at the UC San Diego IGM Genomics Center utilizing an Illumina NovaSeq 6000 that was purchased with funding from a National Institutes of Health SIG grant (#S10 OD026929). G.J.N was supported in part by the NIH training grant T32 DK007202.